<p>The overexpression of the gene Serpent in the Drosophila wing causes permanent overgrowth and it is sufficient to promote tumour development (Image: Kyra Campbell, IRB Barcelona)</p>
19 Feb 2018

In cancer research, there has been a tendency to differentiate between the genes responsible for tumour development and those that give rise to metastasis and to study these processes separately si

<p>Ernest Giralt</p>
14 Feb 2018

The chemist Ernest Giralt (Viladecans, 1948) is the head of the Peptides a

<p>The image shows a metastatic colon tumour infiltrated by the immune system (brown) after combined treatment with the TGF-beta inhibitor and immunotherapy.  (Author: Daniele Tauriello, IRB Barcelona)</p>
14 Feb 2018

In a short space of time, immunotherapy, that is to say therapies based on stimulating the immune system against cancer cells, has become a powerful approach to treat cancers such as melanoma and l

30 Jan 2018

The Institute for Research in Biomedicine (IRB Barcelona) has received a bequest of 1,552,655 €, which, to honour the wishes of the donors, will support research into cancer and metastasis.

Investor working

Media mentions

<p>Workshop "Drosophila Melanogaster, a small superhero in the fight against cancer"</p>
19 Feb 2018

“Al càncer, donem-li recerca!”

El Periódico

The newspaper El Periódico has published an interview with Dani Infante, a physicist and cancer patient who organised the event "Al càncer, Donem-li recerca!" on the occasion of International Childhood Cancer Day.

<p>Eduard Batlle, head of the Colorectal Cancer Laboratory at IRB Barcelona</p>
19 Feb 2018

The immunotherapy for the treatment of aggressive colon tumours and their metastasis

TV3, RTVE, Rac1, La Vanguardia, and Ara, among other important media, have published articles about research led by Eduard Batlle, head of the Colorectal Cancer Laboratory at IRB Barcelona, on the effectiveness of treatments that enhance immune system function in colon cancer.

<p>Núria López-Bigas, group leader of the Biomedical Genomics Lab</p>
13 Feb 2018

Interview with Núria López-Bigas from IRB Barcelona


Betevé Notícies interviewed Núria López-Bigas, group leader of the Biomedical Genomics Lab, about the role of women in science. The interview was part of a report for the “International Day of Women and Girls in Science”.

Link to Betevé Notícies

Photo gallery


<p>Sonia Armengou</p>
Sònia Armengou
Section Head of Communications
Tel: +34 93 40 37255

Quick facts about IRB

Quick facts

IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.